Pharmacy Times

JULY 3, 2023

The study also found significant evidence of outcomes disparities between minority populations and White populations.

149

149

PharmaVoice

JULY 3, 2023

From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.

130

130

Pharmacy Times

JULY 3, 2023

All individuals with type 1 diabetes on the therapy had restored insulin secretion, improved glycemic control, improved time-in-range reduction, or elimination of exogenous insulin usage.

123

123

Pharmaceutical Technology

JULY 3, 2023

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119

119

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JULY 3, 2023

Using data from a wide-ranging survey of Medicare enrollees, investigators found that using value weights from participants would have a negative impact on smaller, rural hospitals.

Hospitals 123

Hospitals 123

STAT

JULY 3, 2023

When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.

Medical Schools 118

Medical Schools 118

Drug Store News

JULY 3, 2023

Retail pharmacies could reclaim success by proactively addressing three of today’s most significant challenges.

106

106

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. US drug product quality: drug recalls in FY2022 During the 2022 financial year, 166 manufacturing sites generated 912 drug recalls, the highest number of recalls in five years, according to the data.

FDA 105

FDA Labelling 105

Drug Store News

JULY 3, 2023

The Spot Detergent sheets are free from parabens and phosphates, the company said.

106

106

STAT

JULY 3, 2023

DENVER — The founder of Field Trip , a chain of shuttered ketamine clinics currently facing insolvency, put forward an unexpected theory of how psychedelics work to treat depression last month. “The truth is, almost all of the effect of psychedelic-assisted therapy could be placebo,” said Ronan Levy, speaking at a five-day conference on the emerging field of psychedelic medicine.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

JULY 3, 2023

2023 started with a buzz around ChatGPT, and more generally around the immense potential that generative AI (GenAI) holds.

105

105

Drug Store News

JULY 3, 2023

AAM said in its white paper that recent reports suggest a rise in shortages in 2023.

103

103

STAT

JULY 3, 2023

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.   Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study.

Chemotherapy 102

Chemotherapy 102

Drug Store News

JULY 3, 2023

As part of the #HerestotheFarmer campaign, Bayer will be the presenting sponsor for Luke Bryan’s 2023 Farm Tour.

99

99

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JULY 3, 2023

Don't hold back lab digital transformation Mike.

98

98

Drug Store News

JULY 3, 2023

It’s Like Skin 2-in-1 Concealer + Tint is designed to brighten and blur the skin for a naturally radiant finish, the company said.

98

98

pharmaphorum

JULY 3, 2023

AZ, Daiichi’s TROP2 drug hits the mark in lung cancer Phil.

98

98

Pharmaceutical Technology

JULY 3, 2023

Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.

FDA 98

FDA 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 3, 2023

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin. “We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer,

98

98

pharmaphorum

JULY 3, 2023

Australia first to prescribe MDMA and psilocybin for depression, PTSD Nicole.

98

98

European Pharmaceutical Review

JULY 3, 2023

Positive topline data has been revealed from the pivotal ELATIVE ® Phase III trial of elafibranor , an investigational dual α,δ PPAR agonist for primary biliary cholangitis (PBC). Data showed 51 percent of patients on 80mg of the small molecule treatment elafibranor achieved a cholestasis response compared with four percent on placebo. The Phase III trial enrolled 161 patients.

98

98

STAT

JULY 3, 2023

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that involves both pharmaceutical-based medication and a prescription digital therapeutic. Accessible through the patient’s smartphone, the digital therapeutic will deliver personalized, evidence-based interventions to treat their conditio

98

98

Drug Store News

JULY 3, 2023

Retailers that leverage up-to-date and in-depth insights on in-store habits can tailor their strategies to best service today’s customers.

98

98

Pharmaceutical Technology

JULY 3, 2023

The bioscience company has received $10m Series A financing from asset manager Mercia.

97

97

Drug Store News

JULY 3, 2023

The AI-powered skin care line comprises more than 15 million possible formula combinations that can target multiple skin concerns simultaneously.

98

98

Pharmaceutical Technology

JULY 3, 2023

China has granted approval for Innovent Biologics and IASO Bio Fucaso for treating relapsed or refractory multiple myeloma (RRMM) in adults.

97

97

Drug Store News

JULY 3, 2023

A new survey from Del Monte Foods reveals new insights into snacking habits.

98

98

Outsourcing Pharma

JULY 3, 2023

George Freeman MP, minister of state at the new Department for Science, Innovation and Technology, has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.

90

90

OctariusRx

JULY 3, 2023

Let Freedom Ring! From all of us at OctariusRx, Happy Independence Day! Thank you to all who serve or have served our Nation in pursuit of the freedom we enjoy today and every day! “We’re blessed with the opportunity to stand for something, for liberty and fairness. And these are things worth fighting for, worth devoting our lives to.” – Ronald Reagan The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to a

78

78

Outsourcing Pharma

JULY 3, 2023

RAIR Health, an applied data and AI company focused on the extraction of clinical insights from real world data, has signed a non-exclusive data license agreement with Royal Cornwall Hospitals NHS Trust (RCH) focussed on the field of ophthalmology.

Hospitals 84

Hospitals 84

The Guardian - Pharmaceutical Industry

JULY 3, 2023

Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped Nearly £14bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped. Shares in the Anglo-Swedish pharmaceutical company closed down 8% on Monday after it published the first results from its phase 3 trial for datopotamab deruxtecan, making it the biggest faller among FTSE 100 companies.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies 76

Pharmacy Times

JULY 3, 2023

The collaboration will focus on engaging with health experts and opinion leaders to examine data to gain a better understanding of the role continuous glucose monitoring systems have in personalized therapeutic nutrition.

73

73

Pharma Times

JULY 3, 2023

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

72

72